Patents Represented by Attorney, Agent or Law Firm Karen A. Lowney
  • Patent number: 5972355
    Abstract: The present invention relates to stable water-containing cosmetic or pharmaceutical compositions which comprise a biologically active agent and an enzyme-based oxygen-scavenging antioxidant system. The composition preferably comprises an antioxidant system comprising effective amounts of an oxidase, a substrate for the oxidase, and a peroxidase, and at least one species oxidizable by hydrogen peroxide, such as iodide and/or thiocyanate anions.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: October 26, 1999
    Assignee: E-L Management Corp.
    Inventors: E. Althea Knight, Akshay Talati, Jules Zecchino
  • Patent number: 5959009
    Abstract: The invention relates to waterproof or water resistant compositions for application to the lashes comprising a styrene-ethylene-propylene copolymer as gellant, a film forming agent, and a volatile oil.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: September 28, 1999
    Assignee: E-L Management Corp
    Inventors: Richard A. Konik, Rachel J. Painter, George J. Stepniewski
  • Patent number: 5958976
    Abstract: The invention relates to topical cosmetic or pharmaceutical compositions comprising an anti-stinging effective amount of an amino acid selected from the group consisting of an amino butyric acid, glutamine, glycine, and derivatives thereof, or mixtures thereof, as well as methods of reducing or preventing stinging using such compositions.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: September 28, 1999
    Assignee: E-L Management Corp.
    Inventors: Neelam Muizzuddin, Kenneth D. Marenus, Glen Rein, Mary Steidl Matsui
  • Patent number: 5942212
    Abstract: The present invention relates to a self-tanning composition comprising an effective amount of DHA in combination with an effective amount of a long-chain alpha hydroxy acid(AHA). In a preferred embodiment, the AHA is .alpha.-hydroxy lauric acid.
    Type: Grant
    Filed: May 21, 1997
    Date of Patent: August 24, 1999
    Assignee: E-L Management Corp.
    Inventors: Peter J. Lentini, Paul Tchinnis, Neelam Muizzuddin
  • Patent number: 5939085
    Abstract: Disclosed are skin smoothing compositions containing hydroxyacids or hydroxyacid derivatives, a polymeric film-forming agent, a physical exfoliant, and a pharmaceutically acceptable carrier. Also disclosed are methods for using the skin smoothing compositions to improve the smoothness of human skin.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: August 17, 1999
    Assignee: E-L Management Corp
    Inventors: Michelle Matathia Jacobs, Peter J. Lentini
  • Patent number: 5888251
    Abstract: Hair upon the scalp or eyelashes are treated with hair coloring or mascara compositions in hair or eyelash coloring methods. The hair is typically colored with a mascara brush to achieve streaking and a non-homogenous coloring of the hair upon the scalp or the eyelash. A copaiba resin and a metal containing pigment are combined to obtain the hair coloring product. The resultant product is applied to the hair upon the scalp or the eyelash to effect coloring of the hair upon the scalp or the eyelash.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: March 30, 1999
    Assignee: Aveda Corporation
    Inventors: Stanley Ray Fogg, Timothy Roland Kapsner
  • Patent number: 5874264
    Abstract: The present invention relates to novel purified gibbon ape leukemia receptor proteins and purified DNA sequences encoding these receptor proteins.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: February 23, 1999
    Assignee: American Cyanamid Company
    Inventor: Bryan Mark O'Hara
  • Patent number: 5871758
    Abstract: The present invention relates to a liquid dual phase cosmetic or pharmaceutical composition comprising an oil phase and an aqueous phase, the composition containing as a demixing agent a quaternary nitrogen-containing ether substituted alkoxylated alkyl glucoside. The compositions of the invention are particularly useful as makeup removers.
    Type: Grant
    Filed: December 11, 1996
    Date of Patent: February 16, 1999
    Assignee: E-L Management Corp.
    Inventors: Adrienne Nagy, Linda Najdek, Elena M. Ciriello, Henry Maso, Ralph Vitale
  • Patent number: 5855897
    Abstract: The present invention relates to topical compositions useful in enhancing lipid synthesis in skin comprising an effective amount of cafestol, in combination with a pharmaceutically or cosmetically acceptable carrier. Such compositions are useful in treatment or prevention of dry skin and conditions in which the skin's lipid barrier is defective or damaged.
    Type: Grant
    Filed: September 13, 1996
    Date of Patent: January 5, 1999
    Assignee: E-L Management Corp.
    Inventor: Edward Pelle
  • Patent number: 5846551
    Abstract: Water-based makeup compositions and methods for their preparation are disclosed. The compositions comprise a water-dispersible pigment having a nonionic coating, a lipid vesicle comprising one or more lipid components, and a cosmetically or pharmaceutically acceptable aqueous carrier, and possess unusual stability at low pH. A method for the preparation of such water-based makeup compositions is disclosed as well.
    Type: Grant
    Filed: June 10, 1996
    Date of Patent: December 8, 1998
    Assignee: E-L Management Corp.
    Inventors: Kathleen DaCunha, Linda McKenna, David Chant, Deborah Jennings
  • Patent number: 5817299
    Abstract: The present invention relates to nonchemical sunscreen composition comprising as its active components, in synergistically effective amounts, a plant extract containing at least about 50% by weight of proanthocyanidins, .gamma.-oryzanol, ferulic acid and/or an ester thereof, titanium dioxide and optionally, Scutellaria extract.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: October 6, 1998
    Assignee: E-L Management Corp.
    Inventor: Abul M. Manirazman
  • Patent number: 5814310
    Abstract: The present invention relates to a clear cosmetic stick composition comprising (a) from about 3-15% of a soap gelling agent; (b) from about 10-90% of at least one polyhydric alcohol solvent; and (c) from about 0.5-10% of a combination of the clarifying agents pentadoxynol 200 and ethoxylated jojoba esters. The composition is useful, for example, as the base for a deodorant stick.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: September 29, 1998
    Assignee: E-L Management Corp
    Inventors: Adrienne Nagy, Joanne Leaver, Steven Messin, Donna Meningall
  • Patent number: 5811114
    Abstract: The present invention relates to cosmetic or pharmaceutical compositions containing a preservative-effective amount of hinokitiol-containing microcapsules, the microcapsules comprising a matrix containing collagen and a glycosaminoglycan.
    Type: Grant
    Filed: June 12, 1996
    Date of Patent: September 22, 1998
    Assignee: E-L Management Corp.
    Inventors: Althea Knight, Julius Zecchino, Steven Schnittger
  • Patent number: 5800826
    Abstract: The present invention relates to a protection-effective amount of UV-damaged RNA fragments, in combination with a cosmetically or pharmaceutically acceptable carrier. The compositions are useful in the prevention of skin damage to UV radiation and in preventing photoaging.
    Type: Grant
    Filed: March 5, 1997
    Date of Patent: September 1, 1998
    Assignee: E-L Management Corp.
    Inventors: Thomas Mammone, Michael Ingrassia
  • Patent number: 5789188
    Abstract: A method for detecting a tetracycline efflux pump inhibitor in the presence of tetracycline using a reporter gene system where the tetA promoter directs transcription of a reporter gene (lacZ) while the tetA is under the control of the tet repressor encoded by the tetR gene is described. The method uses a cell having a reporter gene system where the tetA promoter directs transcription of a reporter gene (lacZ) and an active efflux system in which relatively modest levels of the efflux protein encoded by the tetA gene are produced in a constitutive manner, i.e., not under the control of the tet repressor encoded by the tetR gene. Test samples which are inhibitors of the TetA efflux protein will allow accumulation of tetracycline inside the cells at levels which will induce expression of the tetA-lacZ transcriptional fusion to give a positive signal.
    Type: Grant
    Filed: May 13, 1996
    Date of Patent: August 4, 1998
    Assignee: American Cyanamid Company
    Inventors: David Michael Rothstein, Gordon Gerald Guay
  • Patent number: 5705145
    Abstract: Disclosed are cosmetic compositions for providing an artificial tan to skin which comprise dihydroxyacetone and an azole in a cosmetically or pharmaceutically acceptable carrier. Also disclosed is a method for providing an artificial tan to skin which comprises applying dihydroxyacetone and an azole to the skin.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: January 6, 1998
    Assignee: E-L Management Corp.
    Inventors: Saul Miklean, Konstantinos M. Lahanas, Nicolae Vrabie, Edward Pelle, Andrew J. Bevacqua
  • Patent number: 5648066
    Abstract: Disclosed are solid silicone compositions comprising low molecular weight polyethylene solidifying agents and one or more non-volatile silicone fluids, along with a method for their preparation. The compositions are suitable for topical application to skin or hair, and are particularly useful in the preparation of novel skin treatment, hair treatment, lipstick and makeup products.
    Type: Grant
    Filed: October 3, 1995
    Date of Patent: July 15, 1997
    Assignee: Estee Lauder Companies
    Inventor: George J. Stepniewski
  • Patent number: 5633348
    Abstract: The present invention relates to an isolated nucleic acid fragment comprising a nucleic acid sequence coding for an amphotropic retrovirus receptor. This receptor is referred to as GLVR2 and has approximately 62% homology with the GLVR1 gene encoding for Gibbon Ape Leukemia Virus (GALV). Differences for the type of retroviruses interacting with the receptors exist. The protein encoding by the GLVR2 gene, cells transformed or transfected by the gene and vectors containing the gene are also disclosed.
    Type: Grant
    Filed: January 4, 1996
    Date of Patent: May 27, 1997
    Assignee: American Cyanamid Company
    Inventors: Stephen V. Johann, Marja van Zeijl, Bryan M. O'Hara
  • Patent number: 5554507
    Abstract: An isolated nucleic acid sequence is described having at least one siderophore biosynthetic gene from Bacillus subtilis encoding enzymes homologous to enterobactin enzymes EntA, EntB, EntC, EntE, and combinations thereof. Vectors containing the isolated nucleic acid sequence, host cells transformed wth the isolated nucleic acid sequence, and a method for identifying compounds having antibiotic activity against microorganisms with an enterobactin-type siderophore are also described.
    Type: Grant
    Filed: April 22, 1993
    Date of Patent: September 10, 1996
    Assignee: American Cyanamid Company
    Inventors: Trudy H. Grossman, Marcia S. Osburne
  • Patent number: 5550221
    Abstract: The present invention relates to an isolated nucleic acid fragment comprising a nucleic acid sequence coding for an amphotropic retrovirus receptor. This receptor is referred to as GLVR2 and has approximately 62% homology with the GLVR1 gene encoding Gibbon Ape Leukemia Virus (GALV) receptor. Differences in the type of retroviruses interacting with the receptors exist. The protein encoded by the GLVR2, cells transformed or transfected by the gene, and vectors containing the gene are also disclosed.
    Type: Grant
    Filed: April 16, 1993
    Date of Patent: August 27, 1996
    Assignee: American Cyanamid Company
    Inventors: Stephen V. Johann, Marja van Zeijl, Bryan M. O'Hara